DAIICHI SANKYO -About the News Report
TOKYO, Japan - Today, some media in Japan reported that Daiichi Sankyo Co., Ltd. and GlaxoSmithKline plc will establish a vaccine-related joint venture company .
Our company consider vaccines to be a core business segment, and to strengthen our operations we constantly evaluate a wide range of strategic development opportunities.
However, today's media reports are not based on any official announcement by the Daiichi Sankyo Group.
[Editorial queries for this story should be sent to firstname.lastname@example.org]
((Comments on this story may be sent to email@example.com))
Posted: December 2011